Inspirata

Caradigm USA LLC provides solutions for population health management. The company offers enterprise solutions for population health management, including data control, healthcare analytics, care coordination and management, wellness and patient engagement, and identity and access management. It serves ACOs, academic medical centers, government facilities, and community hospitals globally. The company was incorporated in 2012 and is based in Bellevue, Washington. As of June 13, 2018, Caradigm USA LLC operates as a subsidiary of Inspirata, Inc.

Omnyx, LLC is a joint venture between GE Healthcare and UPMC, with locations in Pittsburgh, PA, and Piscataway, NJ. The company specializes in digital pathology, offering an integrated digital workflow solution designed to assist pathology departments in transitioning to an all-digital environment. Omnyx's products include image acquisition devices, workflow software, and consulting services aimed at transforming cancer care through enhanced collaboration and streamlined case management. By closely working with pathologists from UPMC and leveraging its partnership with GE Healthcare, Omnyx focuses on addressing the specific needs of anatomic pathologists globally. Its solutions are intended for in vitro diagnostic use in targeted clinical applications and are also available for research purposes.

Artificial Intelligence in Medicine, Inc. develops tools that leverage Artificial Intelligence (AI) and Natural Language Processing (NLP) to extract cancer related information and data from clinical documents, such as pathology reports, molecular testing reports, treatment plans, and clinician's notes. The company was incorporated in 1983 and is based in Toronto, Canada. As of January 2, 2018, Artificial Intelligence in Medicine, Inc. operates as a subsidiary of Inspirata, Inc.

Precision Medicine Network, Inc. is a company that specializes in a knowledge visualization and decision support platform aimed at enhancing the adoption of precision medicine. Founded in 2011 in Concord, Massachusetts, the company emerged from the Genomic Medicine Initiative at Harvard Medical School. Its platform, known as Crosswalk Insight™: Oncology, is designed to facilitate the integration of precision medicine into clinical practice. The platform serves a diverse range of users, including oncologists, pathologists, pharmaceutical companies, clinical trial developers, and healthcare executives, among others. By providing resources such as tumor images, molecular pathways, and clinical research, Precision Medicine Network aims to bridge gaps between providers, patients, and payers to realize the full potential of precision healthcare. As of 2016, it operates as a subsidiary of Inspirata, Inc.